Santalis Pharmaceuticals Announces Positive Results from a Study of Pediatric Patients with Eczema Atopic Dermatitis Treated with the Santalia AD Over the Counter Therapy Regimen

Press/Media: Press / Media

PeriodFeb 22 2016

Media coverage

1

Media coverage

  • TitleSantalis Pharmaceuticals Announces Positive Results from a Study of Pediatric Patients with Eczema Atopic Dermatitis Treated with the Santalia AD Over the Counter Therapy Regimen
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date2/22/16
    PersonsJohn C Browning